UCP - The non-invasive solution

A unique medical device

EyeOP1, a medical device developed by EYE TECH CARE, is a system which allows the treatment of glaucoma without surgical incision.
 
UCP procedure, treatment of glaucoma by ultrasound, relies on a strategy to reduce the production of aqueous humour by partially coagulating the ciliary body, which is responsible for the secretion of aqueous humor. The treatment is fast, non-invasive and can be performed with the help of a sterile, single-use device consisting of a treatment probe and a positioning cone. The device is connected to the EyeOP1 control module in order to define and control the parameters of treatment.
 
The procedure lasts less than 5 minutes.

HIFU: precision and ease of application

Treatment procedure

The eye is anaesthetised prior to the treatment. Your ophthalmologist and anaesthetist will choose the anaesthesia that works best for you.  
 
The treatment is carried out using a single-use medical device placed on the eye. A preliminary examination allows the appropriate size of the probe to be determined. The ultrasound is delivered to the targeted areas of the ciliary body to be treated.
In the weeks following the treatment, the intraocular pressure is generally reduced as a result of the decrease of aqueous humor produced by the ciliary body, when the treatment has been successful.
 
After the treatment, your ophthalmologist will prescribe an anti-inflammatory treatment and (re)define the eye drops treatment. They will schedule follow-up visits to check the treated eye in the following months. Glaucoma is a chronic disease that requires regular follow-up.

Patients eligible for UCP treatment

Every glaucoma patient is unique.
UCP allows to titrate the dose to the patients' needs. The treatment can be repeated if needed. UCP can be used in patients at different stages of the disease, from moderate glaucoma under maximum hypotensive treatment to more advanced stages of this disease.